Newsletter | May 1, 2026

05.01.26 -- Do Changes Signal The End Of Biosimilar Regulatory Redundancy?

SPONSOR

Webinar: Meeting Pharma Where It Is Today: How to Activate Industrial AI Under GxP, Governance, and Security Constraints

Explore how Industrial AI can move from insight to action in regulated pharma environments. This webinar examines how governance, validation, and human oversight help AI operate safely, securely, and transparently within GxP systems. Learn what’s working today to enable auditable, compliant adoption without compromising control, trust, or operational confidence. Click here to learn more.

FOCUS ON QUALITY/ANALYTICAL METHODS

Do Changes Signal The End Of Biosimilar Regulatory Redundancy?

First came excitement over the looming patent cliff. Then, FDA and EMA took big swings at what many have called redundant work. Combined, they make a more attractive environment for biosimilar developers.

Comparison Of Constant- And Pulsed-Field Electrophoresis

Accurate sizing of large DNA fragments is crucial in long‑read sequencing. Examine how different electrophoresis methods perform with 10–20 kb smears and how to choose the most reliable approach.

Total Protein Stain Normalization Protocol

See how total protein staining offers a robust approach to western blot normalization to minimize variability and improve quantification accuracy, which supports reproducible protein expression.

Design–Build Cleanroom Projects: A Proven Risk Mitigating Methodology

Building the right cleanroom involves critical early decisions. Learn about a methodical framework ensuring flexibility, compliance, and operational readiness from initial concept through delivery.

A Versatile Analytical Approach To Cleaning Validation

Antibody–drug conjugates combine monoclonal antibodies, linkers, and potent cytotoxins, requiring highly sensitive analytics, stringent cleaning validation, and flexible platforms to manage manufacturing.

DVT: A New Paradigm For Life Sciences Validation

Digital validation tools help teams cut cycle times, reduce labor hours, and strengthen compliance. Gain insight into measurable efficiency gains and steps for adopting a digital validation approach.

The Gateway Delivery To The Brain

Nose‑to‑brain delivery enables targeted neurological treatment by using direct neural pathways to boost precision and limit systemic exposure, with new formulations and devices driving rapid progress.

Mastering Modern Recall Management: A 6-Part Journey To Excellence

Explore the rising challenges of recall management in life sciences. This six-part series offers expert insights and unveils a groundbreaking solution set to transform how companies manage recalls.

Liquid Biopsy-Based Detection Of PIK3CA Mutations From cfDNA

Discover how ultra-sensitive digital PCR workflows use an innovative system to enable precise detection of rare PIK3CA mutations in cfDNA and advance personalized cancer treatment.

Sustainable Vaccine Manufacturing: Securing The Future Of Global Health

Find out how next-gen technologies, from mRNA platforms to digital tools, are transforming vaccine manufacturing to make it more sustainable, flexible, and accessible.

A Human-Relevant Model Of The Liver Sinusoid

This organ-on-a-chip model minimizes drug absorption while maintaining the essential architecture. Read more about the specifications of this product, engineered to model the human liver.

Leveraging Advanced Analytical Capabilities To De-Risk Drug Development

Characterizing a molecule's identity enables efficient process development and regulatory compliance. To achieve this, sponsors must leverage advanced analytical techniques that illuminate structure and purity.

QUALITY/ANALYTICAL SOLUTIONS

Forge Biologics: Facilitating External Collaboration With Quality - Veeva

Enable Deeper Characterization During CAR Cell Development - BD Biosciences

High-Purity Analytical Solvents: Consistent Quality For Applicants - Greenfield Global

Gene Optimization And Synthesis - ATUM

Used Applied Biosystems Genetic Analyzer - Federal Equipment Company

SPONSOR

The 2026 ISPE AI in Life Sciences Summit

The 2026 ISPE AI in Life Sciences Summit – Powered by GAMP® will be held 22–23 June in Boston, offering insight into how AI is advancing within the life sciences sector. Sessions explore model governance, data integrity, explainability, and inspection ready design. Attendees gain practical frameworks for integrating AI into GxP workflows and guidance on how to meet evolving regulatory expectations. LEARN MORE

FOCUS ON REGULATORY

Talent, Infrastructure, And Support To Drive Drug Development

Middlesex County, NJ, offers life sciences organizations a deep talent pool, an extensive R&D presence, and dedicated backing by local government investment.

Designing An Environmental Monitoring Solution For GMP Applications

Implement robust contamination control strategies that align with current regulatory requirements. Optimize your environmental monitoring framework through precise design and data-driven analysis.

REGULATORY SOLUTIONS

Regulatory And Biosafety Testing Expertise - MilliporeSigma

Connect With Bioprocess Online: